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Abstract
The calpain inhibitor A-705253 and the Naq/Hq-
exchange inhibitor Cariporide were studied in isolated
perfused rabbit hearts subjected to 60 min occlusion of
the ramus interventricularis of the left coronary artery
(below the origin of the first diagonal branch), followed
by 120 min of reperfusion. The inhibitors were added to
the perfusion fluid solely or in combination at the begin-
ning of reperfusion. Hemodynamic monitoring and bio-
chemical analysis of perfusion fluid from the coronary
outflow were performed. Myocardial infarct size and area
at risk (transiently not perfused myocardium) were deter-
mined from left ventricular slices after a special staining
procedure with Evans blue and 2,3,5-triphenyltetrazolium
chloride. The infarcted area (dead myocardium) was
72.7"4.0% of the area at risk in untreated controls, but
was significantly smaller in the presence of the inhibitors.
The largest effect was observed with 10-6 M A-705253,
which reduced the infarcted area to 49.2"4.1% of the
area at risk, corresponding to a reduction of 33.6%. Cari-
poride at 10-6 M reduced the infarct size to the same
extent. The combination of both inhibitors, however, did
not further improve cardioprotection. No significant dif-
ference was observed between the experimental groups
in coronary perfusion, left ventricular pressure, heart rate,
or in the release of lactate dehydrogenase and creatine
kinase from heart muscle.
*Dedicated to the memory of Professor Darrel Goll (Tucson,
USA), an extremely successful scientist in the calpain field with
optimism, sense of humor and warmth.
Keywords: coronary occlusion; coronary perfusion;
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Introduction
In addition to their physiological functions in cytoskeletal
remodeling and signal transduction, calpains (calcium-
dependent cytosolic cysteine proteases) are also impli-
cated in pathophysiological processes, especially with
disturbed calcium homeostasis (Goll et al., 2003). Thus,
calpains were found to be involved in myocardial tissue
damage resulting from ischemia and reperfusion, such as
sarcomere disorder, desmin degradation and proteolysis
of calspectin and fodrin (Yoshida et al., 1995; Papp et al.,
2000; Fukunaga et al., 2006). Calpain activity increases
during myocardial hypoxia (Iizuka et al., 1991) and
mechanical unloading of the heart (Razeghi et al., 2007),
and activated calpains were localized by specific anti-
bodies in infarcted regions of the human heart (Kunimat-
su et al., 1999). Calpain inhibition, on the other hand,
attenuates or prevents myocardial tissue damage and
mitochondrial dysfunction by ischemia and reperfusion
(Neuhof et al., 2003). Increased calpain activity during
hypoxia (Iizuka et al., 1991) can be reduced with peptidyl
aldehyde calpain inhibitor-I. Calpain inhibitors are also
found to be protective in prolonged hypothermic cardiac
preservation (Saito et al., 1999), in virus-induced apop-
totic myocardial injury (DeBiasi et al., 2001) and against
structural and contractile dysfunction in atrial fibrillation
(Xue et al., 2007). So far, only a few studies are available
regarding the effect of calpain inhibition in experimental
models of myocardial infarction, in which the infarct size
could be reduced by pretreatment with the calcium-
activated neutral protease inhibitor E-64c in dogs (Toda
et al., 1989) or with calpain inhibitor-I in isolated perfused
rat hearts (Iwamoto et al., 1999; Perrin et al., 2003).
Recently, we could show that myocardial infarct size is
reduced approximately 36.7% by preischemic adminis-
tration of calpain inhibitor A-705253 (Lubisch et al., 2003)
in isolated perfused rabbit hearts (Neuhof et al., 2004)
and in pigs following temporary coronary occlusion
(Khalil et al., 2005). In the present study, we evaluated
the cardioprotective effect of this calpain inhibitor after
postischemic administration, which better reflects the
clinical situation of coronary intervention in acute myo-
cardial infarction.
Since inhibition of the Naq/Hq-exchange inhibitor Cari-
poride is known to attenuate intracellular calcium over-
load (Cun et al., 2007) and calpain activation (Chen et al.,
2002) and to reduce myocardial infarct size after preis-
chemic administration in a pig model (Klein et al., 1995),
we also studied the effect of Cariporide without and
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Figure 1 Time course of coronary perfusion of isolated perfused rabbit hearts subjected to transient occlusion of the ramus inter-
ventricularis of the left coronary artery for 60 min, followed by 120 min of reperfusion.
Control experiments without inhibitor are represented by a solid line and inhibitor treated hearts by dotted lines. Data are expressed
as means"SEM.
in combination with A-705253 after postischemic
administration.
Results
Exclusion of experiments from statistical analysis
Out of 10 control experiments without inhibitor, 2 had to
be ended untimely because of severe arrhythmias and
ventricular fibrillation. Likewise, 2 out of 10 experiments
with an A-705253 10-6 M inhibitor concentration, and 1
heart out of 9 experiments each with inhibitor concentra-
tions of 10-7 M or 10-8 M had to be ended also because
of the severe arrhythmias and ventricular fibrillation. Fur-
thermore, 1 experiment out of 9 with Cariporide (10-6 M)
and 3 experiments out of 11 treated with A-705253
(10-6 M)qCariporide (10-6 M) also had to be ended
untimely because of ventricular fibrillation. Due to imper-
fect staining 1 heart out of the A-705253 (10-6 M) and
Cariporide (10-6 M) treatment group each had to be
excluded from histological and statistical analysis.
The high exclusion rate due to severe arrhythmias and
ventricular fibrillation, as usually observed in animal mod-
els of myocardial infarction (Ravn et al., 1999; Waagstein
et al., 1999), however, did not differ significantly between
the experimental groups, and thus did not influence the
results.
Coronary perfusion, systolic left ventricular
pressure, and heart rate
Coronary occlusion was immediately followed by a
significant (p-0.01) reduction of the coronary perfusion
by approximately 16.9% from its baseline at 29.7"0.6 to
24.7"0.5 ml/min in all perfused hearts (ns48). With
reperfusion, coronary flow increased initially about 6.7%
to 26.2"0.7 ml/min. After 10 min of reperfusion, the flow
rate continuously decreased again to a range between
18.3 and 21.1 ml/min up to the end of the experiment.
Untreated and treated hearts showed the same reaction
(Figure 1).
Similarly, systolic left ventricular pressure dropped sig-
nificantly (p-0.01) in all perfused hearts (ns48) immedi-
ately after coronary occlusion as a mean to approxi-
mately 26.3% from its baseline of 81.4"2.1 to
69.0"2.0 mm Hg and did not recover any more during
reperfusion (Figure 2).
Heart rate was in the range between 185 and 154 min-1
during the steady state period and only lightly dropped
to a range between 156 and 123 beats min-1 up to the
end of reperfusion.
There was no significant difference in the reaction of
coronary perfusion, systolic left ventricular pressure, and
heart rate between the experimental groups.
Enzyme release from heart muscle and potassium
concentration
The concentrations of lactate dehydrogenase and crea-
tine kinase in the perfusate increased significantly
(p-0.001) during reperfusion in all experiments (Figure 3).
Lactate dehydrogenase increased approximately 28.8 up
to 57.3 U/l and creatine kinase approximately 65.0 up to
109.8 U/l. No significant difference, however, was found
between the different experimental groups. Potassium
level in the perfusion fluid remained constant between
4.587"0.078 and 4.812"0.044 mM during all experi-
ments.
Area at risk and infarct size
The area of myocardium, the so-called area at risk below
the level of coronary occlusion, which was temporarily
excluded for 60 min from perfusion, was 42.4"1.3% of
the total left ventricle wall in all evaluated hearts (ns46)
without a significant difference between the experimental
groups. An infarct size (dead tissue/necrosis) of
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Figure 2 Time course of systolic left ventricular pressure of isolated perfused rabbit hearts subjected to transient occlusion of the
ramus interventricularis of the left coronary artery for 60 min, followed by 120 min of reperfusion.
Control experiments without inhibitor are represented by a solid line and inhibitor treated hearts by dotted lines. Data are expressed
as means"SEM.
72.7"4.0% of the area at risk was observed in untreated
control hearts after 120 min of reperfusion (Figure 4). In
the presence of calpain inhibitor A-705253 using a con-
centration of 10-8 M in the perfusion fluid, the infarcted
area was not significantly reduced to 63.9"3.9% of the
area at risk. With increasing inhibitor concentrations,
however, the infarct size decreased significantly (p-0.01)
to 49.2"4.1% with 10-7 M and to 48.3"2.3% with 10-6 M,
corresponding to an infarct reduction of 33.6%. Sole
addition of Cariporide (10-6M) or addition of Cariporide
(10-6 M) in combination with A-705253 (10-6 M) resulted in
a significant (p-0.01) infarct size reduction to 50.2"3.4%
and 52.1"3.7%, respectively, of the area at risk.
Discussion
This study demonstrates for the first time a postischemic
cardioprotective effect of calpain inhibition by A-705253
or inhibition of the Naq/Hq-exchanger by Cariporide in
a model of myocardial infarction in isolated perfused rab-
bit hearts. Both inhibitors significantly reduced the infarct
size, when administered with the beginning of reperfu-
sion after coronary occlusion. Even with postischemic
administration of these inhibitors infarct size could be
reduced around an almost equal degree (33.6%) as with
preischemic treatment (36.7%; Neuhof et al., 2004) in an
identical model. These findings suggest that the final
infarct size is determined by an ongoing myocardial dam-
age during reperfusion.
Increased attention has been focused over the past
two decades on calpains, besides cardiomyocyte con-
tracture, reactive oxygen species and lysosomal prote-
ases, as leading players in lethal myocardial cell injury
during ischemia and reperfusion. Cytosolic Ca2qoverload
during ischemia and reperfusion (Kihara et al., 1989; Mar-
ban et al., 1990) is considered to be mainly responsible
for the activation of calcium-dependent calpains, local-
ized primarily in the Z-disk/I-band region (Yoshimura
et al., 1986; Kumamoto et al., 1992), and the following
breakdown of myocardial proteins. Thus, the calpain-
dependent degradation of desmin, calspectrin (Yoshida
et al., 1995; Papp et al., 2000), of troponin I and T, and
sarcoplasmic reticulum proteins (Singh et al., 2004), cor-
responding to the myofilament disintegration established
by electron microscopy (Gao et al., 1997; Goette et al.,
2002), has been reported in ischemia-reperfusion mod-
els. Further, calpain activation in ischemia and reperfu-
sion is accompanied by the downregulation of calpa-
statin, its natural inhibitor (Sorimachi et al., 1997; Enns
et al., 2002). Besides direct myofilament disintegration,
mitochondrial dysfunction is also considered to contrib-
ute essentially to cardiac dysfunction and myocyte injury
during ischemia and reperfusion (Lesnefsky et al., 2001).
This assumption is supported by observations that cal-
pain inhibition (Neuhof et al., 2003) or the prevention of
calpain activation by Naq/Hq exchange inhibition (Chen
et al., 2002) reduces mitochondrial dysfunction during
myocardial ischemia and reperfusion. Meanwhile, pre-
ischemic calpain inhibition has proved to decrease infarct
size in experimental models in rats (Iwamoto
et al., 1999; Perrin et al., 2003), in rabbits (Neuhof et al.,
2004), and in dogs (Toda et al., 1989; Khalil et al., 2005).
Plasma components and blood cells are not used for
perfusion in our experiments. Thus, a reduced expression
of cell adhesion molecules and neutrophil-mediated
organ injury by calpain inhibition (Ikeda et al., 2002) or
other immunologic reactions are not involved in our
experimental model.
A cardioprotective effect has also been documented of
the Naq/Hq-exchange inhibitor Cariporide in some stud-
ies. Klein et al. (1995) found a reduction of the infarcted
area in reperfused pig hearts following local ischemia by
pretreatment with Cariporide, and Otani et al. (2000)
observed an improved left ventricular function and a
diminished enzyme release upon global ischemia in rat
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Figure 3 Release of lactate dehydrogenase and creatine kinase into the perfusion fluid of isolated perfused rabbit hearts subjected
to transient occlusion of the ramus interventricularis of the left coronary artery for 60 min, followed by 120 min of reperfusion.
Control experiments without inhibitor are represented by a dark-colored column and inhibitor treated hearts by light-colored columns.
Data are presented as means"SD.
hearts. Even in patients undergoing coronary bypass sur-
gery, pretreatment with Cariporide reduced mortality
and the risk of myocardial infarction (Boyce et al., 2003);
however, cerebrovascular events increased (Mentzler
et al., 2008). Cardioprotective effects are also reported in
animal experiments with other Naq/Hq-exchange inhibi-
tors (Knight et al., 2001; Lee et al., 2005) or Naq/Hq-
channel blockers, which limit the upregulation of the
cardiac calpain system after myocardial infarction (Sand-
mann et al., 2002). The Naq/Hq-exchange inhibitor Cari-
poride reduced the infarct size in our experiments in the
same degree as the calpain inhibitor A-705253.
This protective effect can be attributed in our model
exclusively to an influence on the calpain system, since
the combination of both inhibitors did not augment the
protective effect of sole calpain inhibition. The calpain
inhibitor A-705253 is known to directly block the catalytic
center of activated calpains, whereas the Naq/Hq-
exchange inhibitor Cariporide prevents or reduces the
ischemic intracellular Ca2q-overload and thus prevents or
reduces the following calpain activation. This assumption
is supported by Chen et al. (2002) who observed a
reduced calpain activation in postischemic perfused rat
hearts, and by Cun et al. (2007) who found a reduced
calcium overload in global ischemic rabbit hearts pre-
conditioned with Cariporide.
No reduction in the release of lactate dehydrogenase
and creatine kinase by inhibition of calpain or the
Naq/Hq-exchanger, as observed after global myocardial
ischemia (Chen et al., 2002; Neuhof et al., 2003; Liu and
Schellmann, 2003) was found in our study with transient
local ischemia. This may be due to an enzyme loss from
small affected tissue volumes with insufficient concentra-
tion for detection in the open non-recirculating perfusion
system. Differences in coronary flow between treated
and untreated hearts are not expected, because infarcted
areas are reperfused as well. The slowly decreasing cor-
onary flow up to the end of experiment can be related to
an increasing vascular resistance (by endothelial swell-
ing), also observed in normal perfused hearts without
ischemia. Inhibitor treated hearts with significantly
reduced infarct size did not show a better myocardial
function (ventricular pressure performance) than untreat-
ed controls during 120 min of reperfusion. This behavior
becomes clear by observations that salvage of myocar-
dium from necrosis after local ischemia by reperfusion
has little instant effect on systolic myocardial perform-
ance, as its functional recovery takes up to 4 weeks (The-
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Figure 4 Development of myocardial infarction in isolated perfused rabbit hearts after occlusion of the ramus interventricularis of
the left coronary artery for 60 min, followed by 120 min of reperfusion.
Infarct size is expressed in percentage of the area at risk (the transiently not perfused myocardium). Control experiments without
inhibitor are represented by a dark-colored column and inhibitor treated hearts by light-colored columns. Data are presented as
means"SD. Infarct size is significantly reduced by calpain inhibition in all treated hearts compared to untreated controls.
roux et al., 1976; Lavallee et al., 1983; Ellis et al., 1985).
To evaluate not only the salvage from necrosis but also
the return of function, long-term experiments have to be
performed in intact animals. In contrast to the infarct
model in which the time of transient local ischemia is
chosen long enough to develop necrosis, in models of
global ischemia the duration of perfusion stop is restrict-
ed to enable at least a speedy recovery with reperfusion.
As the calpain inhibitor used in our study is also inhib-
iting the lysosomal cysteine proteases cathepsin B and
L, it has to be discussed whether inhibition of both pro-
teases could account for the cardioprotective effect. So
far, only poor information is available for both cathepsins
in the heart. Thus, activation of cathepsin L was found in
the intralysosomal compartment of cardiomyocytes dur-
ing coronary-aortal bypass (Turski and Zaslonka, 2000).
The increase of functional recovery and the decrease of
protein degradation of total activity of cathepsin B and L
and of cathepsin B leakage by cysteine proteinase inhib-
itors in experimental models of myocardial ischemia and
infarction (Tsuchida et al., 1986; Shibata et al., 1992),
however, cannot be related to both proteinases, as these
inhibitors could also inhibit calpains. Since calpain
inhibitor A-705253 and the Naq/Hq-exchange inhibitor
Cariporide reduce infarct size in the same degree with-
out an additional effect by their combination, these find-
ings suggest that cardioprotection in our study is due to
the inhibition of calpain and not of cathepsin B and L.
These cathepsins are not calcium-activated proteases
and their activity would not be inhibited by a Naq/Hq
exchange inhibitor.
Both the calpain inhibitor A-705253 and the Naq/Hq
exchange inhibitor Cariporide showed excellent protec-
tion against myocardial infarction after transient local cor-
onary occlusion when administered with the onset of
reperfusion. These findings may suggest a prophylactic
calpain inhibition in clinical situations of coronary surgery
and coronary angioplasty, which are often threatened by
acute myocardial failure and infarction.
Materials and methods
This study was approved by the Institutional Animal Care and
Use Committee of the Justus Liebig University of Giessen and
was performed in accordance with the guidelines of the National
Institute of Health (USA).
Reagents and materials
Calpain inhibitor A-705253 (Abbott GmbH & Co. KG, Ludwigs-
hafen, Germany) is a representative of a novel class of non-
peptidic calpain inhibitors, as described by Lubisch et al. (2003).
These inhibitors are benzoylalanine-derived ketoamides carrying
vinylbenzyl amino residues in the P2/P3 region and inhibit calpain
in nanomolar concentrations. A-705253 inhibits calpain-I with a
Ki of 27"2.5 nM for the enzyme inhibitor complex. Cathepsins
B and L are inhibited by A-705253 with a Ki of 62"9 and
149"15 nM, respectively. No inhibition is detected for yeast pro-
teasome, papain, and human ICE/caspase1 at concentrations
up to 10 mM. Negative side effects of this inhibitor are not report-
ed up to now and were not observed in our experiments previ-
ously performed in pigs and isolated rabbit hearts. A-705253,
however, is not yet approved for use in humans.
Cariporide (4-isopropyl-3-methylsulfonyl-benzoylguanidin-
methansulfonate), a Naq/Hq-exchange inhibitor (Scholz et al.,
1999), was developed and obtained fromHoechst-Marion-Rous-
sel AG (Frankfurt/Main, Germany). Poly(0-2-hydroxyethyl)-starch
(HAES-steril 10%) was obtained from Fresenius (Bad Hom-
burg, Germany), and Custadiol from Dr. F. Ko¨hler Chemie
GmbH (Alsbach-Ha¨nlein, Germany). Na-pyruvate and 2,3,5-
triphenyltetrazolium chloride were purchased from Sigma-
Aldrich (Deisenhofen, Germany), and Evans blue from Merck
(Darmstadt, Germany).
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Isolated heart preparation
Half-breed rabbits of either sex weighing between 2.5 and 3.2 kg
were anesthetized with pentobarbital sodium (60–80 mg/kg) and
anticoagulated with heparin sodium (1000 IU/kg) injected into an
ear vein. A tracheotomy was performed, and the rabbits were
mechanically ventilated with room air by means of a Starling
pump (B. Braun, Melsungen, Germany). The thorax was opened
via the diaphragm followed by a median sternotomy. The aorta
was cannulated retrogradely and cardioplegia was induced by
injection of 25–30 ml of ice-cold (48C) Bretschneider solution
(Custadiol). The hearts were excised, mounted onto a modified
Langendorff perfusion system and excess tissue was removed.
A latex balloon (1.3 ml capacity) for pressure monitoring was
inserted into the left ventricle and connected to a second extra-
corporeal circuit according to the ‘working’ heart model, as
described by Bardenheuer and Schrader (1983). Left end-
diastolic influx pressure (preload) was set hydrostatically to
7 mm Hg and ‘aortic’ pressure (afterload) to 50 mm Hg by
means of a water filled reservoir and the height of the outflow
tube, respectively. After a cardioplegic arrest of 3–4 min, the
hearts were perfused retrogradely with a constant hydrostatic
pressure of 70 mm Hg with oxygenated Krebs-Henseleit-HAES
buffer at 378C, which was filtered by a 0.2-mm Pall filter (Pall
Biomedical Inc., Fajardo, PR, USA). The buffer was bubbled with
a mixture of 95% O2 and 5% CO2 resulting in a PO2 of)400 mm
Hg in the perfusate and )200 mm Hg in the coronary effluent,
and the pH was maintained between 7.35 and 7.45 by increasing
or decreasing the CO2 admixture. During the experiments, the
spontaneously beating hearts were submerged into a container
(25 ml capacity) at 378C filled with the coronary effluent to pre-
vent exsiccation. Coronary perfusion pressure and coronary flow
were measured continuously by a pressure transducer (Combi-
trans, B. Braun) and electromagnetic flow probe (Empo/Gould,
Oxnard, CA, USA), respectively, in the perfusion line. Left ven-
tricular pressure and end-diastolic pressures were measured by
another pressure transducer connected to the balloon inserted
into the cavity of the left ventricle. Isovolumetric left ventricular
pressure was measured intermittently by clamping off the con-
nections to the inflow reservoir and the outflow tube. A bipolar
electrocardiogram was conducted from apex versus heart base.
All these parameters were monitored continuously and recorded
on a multichannel recorder.
Perfusate
For perfusion, a modified Krebs-Henseleit buffer solution (KHHB)
with Na-pyruvate (0.5 g/l) was prepared, and hydroxyethyl starch
(HAES-steril 10%) was added to keep colloid oncotic pressure
between 23 and 25 mm Hg, yielding the following final concen-
trations: starch 50 g/l; Naq 138 mM; Kq 4.5 mM; Mg2q 1.33 mM;
Cl- 135 mM; Ca2q 2.38 mM; glucose 12 mM; Na-pyruvate 4.5 mM,
and HCO3- 12 mM. Osmolality was approximately 330
mosmol/kg. The pH of the perfusate was adjusted to 7.4 with
1 M NaHCO3 before usage. Oncotic pressure and osmolality
were controlled by an Onkometer (BMT 921, Dr. Karl Thomae,
Biberach, Germany) and a Mikro-Osmometer (Roebling Mess-
technik, Berlin, Germany).
Experimental protocol
Perfused hearts were stabilized for 20 min. After this steady
state period, the ramus interventricularis of the left coronary
artery was blocked by means of a Tourniquet just below the
origin of the first diagonal branch for 60 min. Hearts selected for
the study were those that developed a constant systolic left ven-
tricular pressure of more than 60 mm Hg during the steady state
period. After 60 min of occlusion the Tourniquet was reopened
and the coronary arteries reperfused for 120 min.
In 8 perfused hearts each, calpain inhibitor A-705253 was
added to the perfusate from the beginning of reperfusion in final
concentrations of 10-8, 10-7 and 10-6 M, respectively. In 8 exper-
iments the Naq/ Hq-exchange inhibitor Cariporide was admin-
istered in a final concentration of 10-6 M, and in a further 8 hearts
a combination of A-705253 (10-6 M)qCariporide (10-6 M) was
used. Eight hearts were reperfused without inhibitors as control.
Measurements
Isovolumetric left ventricular pressure amplitude and heart rate
were determined by pressure records and electrocardiogram,
respectively. Coronary flow was monitored continuously by an
electromagnetic flow transducer. Samples of coronary effluent
were collected intermittently for control of pH, PO2, and PCO2,
and for determination of creatine kinase and lactate dehydro-
genase activity using kits from Boehringer (Mannheim,
Germany).
Determination of area at risk and infarct size
At the end of each experiment, perfusion was stopped and the
ramus interventricularis of the left coronary artery was closed
again by the Tourniquet. A total of 5 ml of Evans blue (5%) was
injected via the perfusion catheter into the coronary circulation
to stain the non-ischemic zone blue and to demarcate the area
at risk. The atria, right ventricle, and great vessels were removed
and the left ventricle was cut in 7–8 slices of approximately
3 mm thickness, which then were incubated in 2,3,5-
triphenyltetrazolium chloride (1%) for 15 min at a temperature of
378C. By this procedure, normal perfused myocardium was
stained blue and the viable tissue within the area at risk was
stained red, whereas the infarcted dead myocardium remained
unstained. The stained slices were photographed on both sides
by means of a digital camera (Coolpix 950, Nikon Corp., Tokyo,
Japan). The computer programs Paint Shop Pro6 (Jasc Software
Inc., Eden Prairie, MN, USA) and Image J (NIH, Bethesda, MD,
USA) were used for color discrimination and planimetric evalu-
ation of normal perfused myocardium, area at risk, and infarct
size. Both sides of each left ventricle slice were evaluated and
the areas added up, corresponding to their different color. Infarct
size (dead myocardium) was expressed in percentage of area at
risk (the temporarily non-perfused myocardium due to the
60 min of coronary occlusion).
Statistics
The data were analyzed by means of the Statgraphics-Plus sta-
tistical analysis package from Statistical Graphics Corporation
(Rockville, MD, USA). Intergroup analysis was performed by
analysis of variance. Fisher’s LSD test was used for multiple
group comparison. Data are presented as means"standard
error of the mean. A p-value -0.05 was considered as statisti-
cally significant.
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